AN1 0.00% 0.8¢ anagenics limited

Ann: Cellmid to Commence Selling of Evolis into Chinese Market, page-26

  1. 356 Posts.
    lightbulb Created with Sketch. 56
    this market re-rate has been a long time coming and well overdue; even with a current market cap of $30m its still 10 times away from fair value of +$3.

    plenty of upside and exciting times for existing shareholders; however with liquidity firming up and FOMO fever setting in, it will only make it harder for those on the sidelines to take a position (not that I have any sympathy)

    Last edited by David Bo$$: 02/05/18
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.